AMGN

AMGEN INC
$376.35previous close on: 9/16/2026

Company Information

Company Name
AMGEN INC
CIK
CIK0000318154
Category
Large accelerated filer
Ticker: Exchange
AMGN: Nasdaq
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2836
SIC Description
Biological Products, (No Diagnostic Substances)
Ticker
AMGN

SEC filing data through

Insider Sentiment

Last purchase
Last sale
2026-05-04
Shares purchased (TTM)
0
Shares sold (TTM)
70,704
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
410,506,543
Shares outstanding
540,000,000
Ownership
76.02%
+0.74% Y/Y

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
1-month reaction
6.65%
3-month reaction
Pending
Drift continued4/11 (36%)
Faded / reversed7/11 (64%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value13,98912,0389,1299,4458,0288,81011,9739,0119,3019,70810,94434,741
Available For Sale Securities Debt Securities Current----------00
Accounts Receivable Net Current10,2279,1389,5708,4908,7018,1326,7827,3176,9346,7767,2686,145
Inventory Net6,2206,1866,2256,3466,5836,7296,9987,3627,9958,7249,5185,026
Other Assets Current4,5254,1134,1333,6043,4223,2583,2773,0762,9762,8212,6022,565
Assets Current34,96131,47529,05727,88526,73426,92929,03026,76627,20628,02930,33248,477
Property Plant And Equipment Net8,5478,2167,9137,2206,8556,6816,5436,1566,0976,0025,9415,563
Intangible Assets Net Excluding Goodwill20,48721,37922,27623,13924,61425,72427,69928,92030,17231,37232,64113,150
Goodwill18,66818,67418,68018,67618,67418,64518,63718,65818,61618,57018,62915,509
Other Assets Noncurrent12,97612,76012,66013,22111,02011,3889,93010,3838,8169,0079,6117,835
Assets95,63992,50490,58690,14187,89789,36791,83990,88390,90792,98097,15490,534
Liabilities Current
Accounts Payable Current2,8652,9352,3672,8383,0102,4061,9082,1472,2671,6281,5901,358
Accrued Liabilities Current17,19216,58318,52316,80015,02217,23417,64114,62113,72214,12715,35914,168
Long Term Debt Current5,4455,4374,5992,1532,4443,3683,5503,5445,5283,9591,4431,428
Liabilities Current25,50224,95525,48921,79120,47623,00823,09920,31221,51719,71418,39216,954
Long Term Debt Noncurrent51,85951,88650,00552,43453,76054,01356,54956,85457,11760,06163,17059,040
Deferred Income Tax Liabilities Net1,3011,3441,3661,4581,3861,5101,6161,7111,7801,8622,354-
Liability For Uncertain Tax Positions Noncurrent2,8442,7642,6902,6162,5112,4192,3492,2802,2053,9644,6804,579
Other Liabilities Noncurrent2,4452,3652,3782,2232,3362,2102,3492,1992,3632,3572,3262,305
Stockholders Equity
Common Stocks Including Additional Paid In Capital34,08234,03034,02333,84133,68033,57833,53333,39333,20433,08233,07032,753
Retained Earnings Accumulated Deficit-22,275-24,650-25,107-23,800-25,708-27,140-27,590-25,530-27,124-27,870-26,549-24,971
Accumulated Other Comprehensive Income Loss Net Of Tax-119-190-258-422-544-231-66-336-155-190-289-126
Stockholders Equity11,6889,1908,6589,6197,4286,2075,8777,5275,9255,0226,2327,656
Liabilities And Stockholders Equity95,63992,50490,58690,14187,89789,36791,83990,88390,90792,98097,15490,534
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized2,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,750
Shares Outstanding541540539539538538537538537536535535

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

AMGEN INC (AMGN) — SEC Financial Statements & Analysis

AMGEN INC (AMGN) is a biological products, (no diagnostic substances) company, incorporated in DE. AMGEN INC trades on Nasdaq as: AMGN. AMGEN INC (AMGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, AMGEN INC carries a market cap of $194.41B, a P/E ratio of 22.24x, a P/B ratio of 16.63x, a P/S ratio of 5.10x, an enterprise value of $237.72B, and an EV/EBITDA multiple of 14.77x. On profitability, it posts a gross margin of 69.52%, an operating margin of 29.99%, a net margin of 22.95%, a Return on Equity (ROE) of 91.47%, a Return on Assets (ROA) of 9.53%, and a Return on Invested Capital (ROIC) of 17.33%. Per share, it reports EPS of $16.19, diluted EPS of $16.07, free cash flow per share of $18.84, and a dividend per share of $9.79. Over the trailing year, it posted revenue growth of 9.10% year-over-year, net income growth of 32.09% year-over-year, and EPS growth of 31.60% year-over-year. On the balance sheet, it maintains a current ratio of 1.37x, a quick ratio of 1.13x, working capital of $9.46B, a debt-to-equity ratio of 2.18x, a debt ratio of 0.27, an interest coverage ratio of 4.28x, free cash flow of $10.18B (TTM), and net debt of $43.31B. Figures sourced from SEC EDGAR.

Market Cap
$194.41B
P/E TTM
22.24x
EPS TTM
$16.19
P/B TTM
16.63x
ROE TTM
91.47%
ROA TTM
9.53%
Debt To Equity
2.18x
Free Cash Flow TTM
$10.18B
Net Revenue TTM Growth 1Y
9.10%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AMGEN INC in?

AMGEN INC (AMGN) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does AMGN trade on?

AMGEN INC (AMGN) trades on the Nasdaq.

Where is AMGEN INC incorporated?

AMGEN INC is incorporated in DE.

When was AMGEN INC (AMGN)'s most recent SEC filing?

AMGEN INC (AMGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is AMGN's market cap?

AMGEN INC (AMGN) has a market capitalization of $194.41B as of 2026-06-30.

What is AMGN's P/E ratio?

AMGEN INC (AMGN)'s trailing twelve month P/E ratio is 22.24x as of 2026-06-30.

What is AMGN's EPS (earnings per share)?

AMGEN INC (AMGN)'s trailing twelve month EPS is $16.19 as of 2026-06-30.

What is AMGN's ROE (return on equity)?

AMGEN INC (AMGN)'s trailing twelve month Return on Equity (ROE) is 91.47% as of 2026-06-30.

What is AMGN's ROA (return on assets)?

AMGEN INC (AMGN)'s trailing twelve month Return on Assets (ROA) is 9.53% as of 2026-06-30.

What is AMGN's ROIC (return on invested capital)?

AMGEN INC (AMGN)'s trailing twelve month Return on Invested Capital (ROIC) is 17.33% as of 2026-06-30.

What is AMGN's EV/EBITDA?

AMGEN INC (AMGN)'s trailing twelve month EV/EBITDA is 14.77x as of 2026-06-30.

Wall Street's data.
Main Street's price.